Pleno Secures $25M Funding for Commercial Launch, Appoints New CEO from Illumina
Funding:
Pleno, a multiomics startup, has raised $25 million in funding to support its commercial launch24.
New CEO:
The company has appointed Vik Vaz, MD, as its new CEO, who comes from Illumina, bringing clinical expertise and commercial experience in the life sciences sector25.
Background:
Pleno's founder, Pieter van Rooyen, previously co-founded Edico Genome, which was acquired by Illumina in 2018 for $100 million. Edico developed the DRAGEN IT platform for DNA analysis15.
Platform:
Pleno aims to provide a system that can simultaneously analyze DNA, RNA, methylation structures, and protein content of patient samples, enhancing multiomics capabilities1.
Commercial Launch:
The funding will be used to further develop and commercialize Pleno's multiomics platform, expanding its team and operations24.
Sources:
1. https://www.fiercebiotech.com/medtech/sequencing-startup-pleno-prospers-40m-funding-round
2. https://sdbn.org/san-diego-biotech-jobs/2024/12/12/quality-control-lead-san-diego-ca/
4. https://ftp.digitalpharmaeurope.com/cro/all-rumors-are-true-syneos-health-inks-71b-acquisition-investment-firm-trio